| Literature DB >> 28414314 |
Shunsuke Kon1, Kojiro Ishibashi1, Hiroto Katoh1, Sho Kitamoto1, Takanobu Shirai1, Shinya Tanaka1, Mihoko Kajita1, Susumu Ishikawa1, Hajime Yamauchi1, Yuta Yako1, Tomoko Kamasaki1, Tomohiro Matsumoto1, Hirotaka Watanabe1, Riku Egami1, Ayana Sasaki1, Atsuko Nishikawa1, Ikumi Kameda1, Takeshi Maruyama1, Rika Narumi1, Tomoko Morita1, Yoshiteru Sasaki2, Ryosuke Enoki3,4,5, Sato Honma4, Hiromi Imamura6, Masanobu Oshima7, Tomoyoshi Soga8, Jun-Ichi Miyazaki9, Michael R Duchen10, Jin-Min Nam11, Yasuhito Onodera12, Shingo Yoshioka13, Junichi Kikuta13, Masaru Ishii13, Masamichi Imajo14, Eisuke Nishida15, Yoichiro Fujioka16, Yusuke Ohba16, Toshiro Sato17, Yasuyuki Fujita1.
Abstract
Recent studies have revealed that newly emerging transformed cells are often apically extruded from epithelial tissues. During this process, normal epithelial cells can recognize and actively eliminate transformed cells, a process called epithelial defence against cancer (EDAC). Here, we show that mitochondrial membrane potential is diminished in RasV12-transformed cells when they are surrounded by normal cells. In addition, glucose uptake is elevated, leading to higher lactate production. The mitochondrial dysfunction is driven by upregulation of pyruvate dehydrogenase kinase 4 (PDK4), which positively regulates elimination of RasV12-transformed cells. Furthermore, EDAC from the surrounding normal cells, involving filamin, drives the Warburg-effect-like metabolic alteration. Moreover, using a cell-competition mouse model, we demonstrate that PDK-mediated metabolic changes promote the elimination of RasV12-transformed cells from intestinal epithelia. These data indicate that non-cell-autonomous metabolic modulation is a crucial regulator for cell competition, shedding light on the unexplored events at the initial stage of carcinogenesis.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28414314 DOI: 10.1038/ncb3509
Source DB: PubMed Journal: Nat Cell Biol ISSN: 1465-7392 Impact factor: 28.824